巨噬細胞炎性蛋白1β(MIP1b)活性蛋白
Active Macrophage Inflammatory Protein 1 Beta (MIP1b)
CCL4; ACT2; G-26; LAG1; MIP1-B; SCYA4; Chemokine C-C-Motif Ligand 4; Small Inducible Cytokine A4; Homologous To Mouse Mip-1b
- 編號APA093Hu61
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點4.5
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1320 ¥ 3300 ¥ 6600 ¥ 19800 ¥ 49500
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Macrophage Inflammatory Protein 1 Beta (MIP1b), also known as CCL4, is a cytokine belonging to the CC chemokine family that is secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells, and pulmonary smooth muscle cells. As a chemokine, MIP1b binds to the G-protein-coupled receptors CCR5 and CCR8, acting as a chemical attractant for natural killer cells, monocytes, and various other immune cells at sites of inflected or damaged tissue. At the same time, MIP1b can also retain the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T-cells. Chemokine C-C-Motif Receptor 7 (CCR7) can interact with MIP1b.Thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human MIP1b and recombinant mouse CCR7. Briefly, biotin-linked MIP1b were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to CCR7-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human MIP1b and recombinant mouse CCR7 was shown in Figure 1, the EC50?for this effect is 1.17 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPA093Hu01 | 巨噬細胞炎性蛋白1β(MIP1b)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA093Hu61 | 巨噬細胞炎性蛋白1β(MIP1b)活性蛋白 | Cell?culture;?Activity?Assays. |
APA093Hu62 | 巨噬細胞炎性蛋白1β(MIP1b)活性蛋白 | Cell?culture;?Activity?Assays. |
APA093Hu01 | 巨噬細胞炎性蛋白1β(MIP1b)活性蛋白 | Cell?culture;?Activity?Assays. |
EPA093Hu61 | 巨噬細胞炎性蛋白1β(MIP1b)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA093Hu62 | 巨噬細胞炎性蛋白1β(MIP1b)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA093Hu02 | 巨噬細胞炎性蛋白1β(MIP1b)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA093Hu02 | 巨噬細胞炎性蛋白1β(MIP1b)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA093Hu01 | 巨噬細胞炎性蛋白1β(MIP1b)多克隆抗體 | WB; IHC; ICC; IP. |
MAA093Hu22 | 巨噬細胞炎性蛋白1β(MIP1b)單克隆抗體 | WB; IHC; ICC; IP. |
SEA093Hu | 巨噬細胞炎性蛋白1β(MIP1b)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA093Hu | 巨噬細胞炎性蛋白1β(MIP1b)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Inhalation Toxicology | Age influence on hypersensitivity pneumonitis induced in mice by exposure to Pantoea agglomerans [Pubmed: 24044680] |
PLoS One. | Megakaryocytic leukemia 1 (MKL1) regulates hypoxia induced pulmonary hypertension in rats. [Pubmed: 24647044] |
PLOS ONE | Megakaryocytic Leukemia 1 (MKL1) Regulates Hypoxia Induced Pulmonary Hypertension in Rats [Pubmed:Pmc3960100] |
Cell Physiol Biochem | MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1 [PubMed: 26159489] |
Am J Alzheimers Dis Other Demen. | Tong Luo Jiu Nao, a Chinese Medicine Formula, Reduces Inflammatory Stress in a Mouse Model of Alzheimer's Disease [Pubmed:26993489] |
Pharmacological Reports | The Association between Inflammatory Markers (iNOS, HO-1, IL-33, MIP-1β) and Depression with and without Posttraumatic Stress Disorder [10.1016:j.pharep.2018.06.001] |
Metabolic Brain Disease | Neuroprotective effects of Bacopa monnieri in Parkinson's disease model [Pubmed: 31834548] |